“We are humbled and honored for the recognition we received with the Medtrade Provider’s Choice Award."
(PRWEB) April 19, 2012
Somnetics International Inc., the Minneapolis-based maker of Transcend®, today announced that Transcend was awarded the “Providers Choice Award” at the close of the Medtrade Spring Conference held April 10-12 in Las Vegas, as voted on by the show attendees. The Provider’s Choice Award was given to Transcend for best exemplifying optimal use of technology.
Transcend is changing the way CPAP therapy is delivered as the world’s smallest, lightest, most portable and flexible continuous positive airway pressure (CPAP) and battery system. It is first in the industry to bring proven Waterless Humidification™ technology and lightweight, long-life battery systems to CPAP users, making Transcend the preferred choice for travel and home use.
Clarence Johnson, president, Somnetics said, “We are humbled and honored for the recognition we received with the Medtrade Provider’s Choice Award. This is the third prestigious award we’ve received in six months for product innovation and addressing the unmet needs of the CPAP market.”
For information about Transcend visit http://www.mytranscend.com or call 877-621-9626.
Transcend is the smallest, lightest and most portable CPAP and battery system available. The Transcend Sleep Apnea Therapy System offers options that make this the most flexible CPAP choice for travel and home use. Options include the lightweight, long-life P4 Overnight Battery System™ and the P8 Multi-Night Battery System™ to provide reliable power in remote locations and during power outages. Two Waterless Humidification™ system options harness innovative proprietary heat moisture exchange (HME) technology that eliminates the hassles of traditional heated humidifiers. Transcend is protected by several issued and pending US and foreign patents.
Somnetics International, Inc. is a privately-held medical device company based in Minneapolis, Minn. It is an emerging leader in customer-driven design, development and production of respiratory medical devices to treat sleep apnea and related issues. Somnetics’ mission is focused on integrating technology, customer input and employee creativity to provide innovative, high quality products that improve quality of life for people with respiratory disorders. Transcend received the 2011 Medtrade Innovation Award, the 2012 Medtrade Spring Provider’s Choice Award, and the 2012 Best Practices Award for Product Differentiation in the Sleep Disordered Breathing market from Frost & Sullivan. Somnetics received FDA market clearance for the Transcend CPAP machine in July 2010 and CE Mark in February 2012. Transcend and associated technology is protected by several issued and pending U.S. and foreign patents.